文献速递新生儿儿童消化与营养儿童内分泌与遗传代谢

中国新生儿基因组计划:新生儿非结合高胆红素血症的临床与遗传病因

Clinical and Genetic Etiologies of Neonatal Unconjugated Hyperbilirubinemia in the China Neonatal Genomes Project.
PubMed 文献 · J Pediatr · 2021-12-23

该研究纳入中国新生儿基因组计划中1412例非结合高胆红素血症新生儿,分析临床数据及2742个基因的靶向测序。68%患儿找到已知临床病因,55例(4%)检出基因变异,G6PD和UGT1A1占相关变异患者的76%。

要点

  • 37%患儿为重度非结合高胆红素血症,总胆红素水平达到换血推荐标准。
  • 轻度组最常见临床病因为感染(17%),重度组为混合因素(21%)。
  • 55例(4%)检出基因变异,G6PD和UGT1A1变异占45例相关变异患者的76%。

核心结论

  • 约三分之二的非结合高胆红素血症新生儿可找到已知临床病因,且病因随胆红素水平不同而变化。
  • 4%的患儿检出基因变异,G6PD和UGT1A1是最常见的变异基因。

研究设计与样本

  • 研究纳入2016年8月至2019年9月中国新生儿基因组计划中1412例非结合高胆红素血症新生儿(总血清胆红素大于年龄的第95百分位)。
  • 分析临床数据及2742个基因的靶向面板测序数据,包括已知非结合高胆红素血症相关基因。

主要发现

  • 1412例患儿中37%为重度非结合高胆红素血症,总血清胆红素水平达到换血推荐标准。
  • 68%的患儿找到已知临床病因;轻度组最常见为感染(17%),重度组最常见为混合因素(21%,以感染合并血管外出血最常见)。
  • 55例(4%)检出基因变异,其中45例为与非结合高胆红素血症相关基因的变异,10例为额外遗传发现。
  • 45例相关变异患者中,基因主要涉及酶缺陷、代谢/生化紊乱和红细胞膜缺陷;G6PD和UGT1A1变异在45例中检出34例(76%)。

关键数值与推荐

  • 非结合高胆红素血症定义为总血清胆红素大于年龄的第95百分位。
  • 重度非结合高胆红素血症定义为总血清胆红素水平达到换血推荐标准。

临床怎么用

  • 对非结合高胆红素血症新生儿应评估已知临床病因,且病因构成随胆红素严重程度不同而变化。
  • 即使已识别临床病因,仍可考虑基因检测,G6PD和UGT1A1是常见变异基因。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the clinical and genetic causes of neonatal unconjugated hyperbilirubinemia. STUDY DESIGN: We included 1412 neonates diagnosed with unconjugated hyperbilirubinemia (total serum bilirubin >95 percentile for age), from the China Neonatal Genomes Project between August 2016 and September 2019, in the current study. Clinical data and targeted panel sequencing data on 2742 genes including known unconjugated hyperbilirubinemia genes were analyzed. RESULTS: Among the 1412 neonates with unconjugated hyperbilirubinemia, 37% had severe unconjugated hyperbilirubinemia, with total serum bilirubin levels that met the recommendations for exchange transfusion. Known clinical causes were identified for 68% of patients. The most common clinical cause in the mild unconjugated hyperbilirubinemia group was infection (17%) and in the severe group was combined factors (21%, with infection combined with extravascular hemorrhage the most common). A genetic variant was observed in 55 participants (4%), including 45 patients with variants in genes associated with unconjugated hyperbilirubinemia and 10 patients with variants that were regarded as additional genetic findings. Among the 45 patients identified with unconjugated hyperbilirubinemia-related variants, the genes were mainly associated with enzyme deficiencies, metabolic/biochemical disorders, and red blood cell membrane defects. G6PD and UGT1A1 variants, were detected in 34 of the 45 patients (76%). CONCLUSIONS: Known clinical causes, which varied with bilirubin levels, were identified in approximately two-thirds of the patients. Genetic findings were identified in 4% of the patients, including in patients with an identified clinical cause, with G6PD and UGT1A1 being the most common genes in which variants were detected.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Mei H, Dong X, Wu B, et al. Clinical and Genetic Etiologies of Neonatal Unconjugated Hyperbilirubinemia in the China Neonatal Genomes Project. J Pediatr. 2021. PMID: 34953813. doi:10.1016/j.jpeds.2021.12.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。